{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T19:05:21Z","timestamp":1773428721629,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jhep.2005.02.027","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T12:01:14Z","timestamp":1115294474000},"page":"670-678","source":"Crossref","is-referenced-by-count":33,"title":["Neutralization of tumor necrosis factor abrogates hepatic failure induced by \u03b1-galactosylceramide without attenuating its antitumor effect in aged mice"],"prefix":"10.1016","volume":"43","author":[{"given":"Takuo","family":"Inui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Habu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariyoshi","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhji","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2005.02.027_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4049\/jimmunol.147.4.1214","article-title":"Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver","volume":"147","author":"Seki","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib2","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.154.9.4333","article-title":"Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12","volume":"154","author":"Hashimoto","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.182.3.633","article-title":"NK1.1+ T cell receptor-alpha\/beta+ cells: new clues to their origin, specificity, and function","volume":"182","author":"MacDonald","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hep.510260208","article-title":"Mouse liver T cells: their change with aging and in comparison with peripheral T cells","volume":"26","author":"Tsukahara","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.027_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.180.3.1097","article-title":"An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans","volume":"180","author":"Lantz","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib6","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.182.6.2091","article-title":"Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes","volume":"182","author":"Bendelac","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/eji.1830230151","article-title":"NK1.1+CD4+CD8- thymocytes with specific lymphokine secretion","volume":"23","author":"Arase","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib8","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.160.7.3522","article-title":"Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction","volume":"160","author":"Ogasawara","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of V alpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jhep.2005.02.027_bib10","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.4049\/jimmunol.166.11.6578","article-title":"Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice","volume":"166","author":"Nakagawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib11","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.4049\/jimmunol.172.11.6550","article-title":"Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide","volume":"172","author":"Nakagawa","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib12","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.4049\/jimmunol.169.11.6127","article-title":"Age-associated augmentation of the synthetic ligand-mediated function of mouse NK1.1 Ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro","volume":"169","author":"Inui","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.510230103","article-title":"Cytokine inhibition of the hepatitis B virus core promoter","volume":"23","author":"Romero","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.027_bib14","first-page":"41","article-title":"Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha","volume":"54","author":"Alvarado Esquivel","year":"2002","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.jhep.2005.02.027_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(89)90208-6","article-title":"Tumor necrosis factor is a terminal mediator in galactosamine\/endotoxin-induced hepatitis in mice","volume":"38","author":"Tiegs","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2005.02.027_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.1840160308","article-title":"HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma","volume":"16","author":"Gilles","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.027_bib17","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.4049\/jimmunol.158.12.5692","article-title":"Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice","volume":"158","author":"Nakamoto","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib18","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.159.8.3961","article-title":"IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice","volume":"159","author":"Tsutsui","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1600-0528.2002.017411.x","article-title":"Cytokine regulation of liver injury and repair","volume":"174","author":"Diehl","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2005.02.027_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2005.02.027_bib21","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.4049\/jimmunol.160.8.4082","article-title":"Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis","volume":"160","author":"Ksontini","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib22","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2005.02.027_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm0497-409","article-title":"Essential roles of the Fas ligand in the development of hepatitis","volume":"3","author":"Kondo","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2005.02.027_bib25","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4049\/jimmunol.159.3.1537","article-title":"Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice","volume":"159","author":"Toyabe","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.191.1.105","article-title":"Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis","volume":"191","author":"Kaneko","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib27","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2005.02.027_bib28","first-page":"155","article-title":"Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4-octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice","volume":"8","author":"Motoki","year":"1996","journal-title":"Oncol Res"},{"key":"10.1016\/j.jhep.2005.02.027_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/excr.2001.5446","article-title":"Growth-related signaling regulates activation of telomerase in regenerating hepatocytes","volume":"273","author":"Inui","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jhep.2005.02.027_bib30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B","article-title":"Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes","volume":"30","author":"Walter","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib31","first-page":"561","article-title":"Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production","volume":"10","author":"Nakagawa","year":"1998","journal-title":"Oncol Res"},{"key":"10.1016\/j.jhep.2005.02.027_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/jhep.2000.18422","article-title":"Induction of murine hepatocyte death by membrane-bound CD95 (Fas\/APO-1)-ligand: characterization of an in vitro system","volume":"32","author":"Schlosser","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.02.027_bib33","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.156.9.3366","article-title":"Liver NK1.1+CD4+alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis","volume":"156","author":"Takeda","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.180.2.423","article-title":"Cytotoxicity of fresh NK1.1+T cell receptor alpha\/beta+ thymocytes against a CD4+8+thymocyte population associated with intact Fas antigen expression on the target","volume":"180","author":"Arase","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2567.1997.00240.x","article-title":"Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand\/Fas molecules","volume":"91","author":"Moroda","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2005.02.027_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.172.1.7","article-title":"Liver is a possible site for the proliferation of abnormal CD3+4-8-double-negative lymphocytes in autoimmune MRL-lpr\/lpr mice","volume":"172","author":"Ohteki","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib37","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.4049\/jimmunol.147.9.2907","article-title":"Expansion of the population of double negative CD4-8-T alpha beta-cells in the liver is a common feature of autoimmune mice","volume":"147","author":"Masuda","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0676.1985.tb00252.x","article-title":"The streaming liver","volume":"5","author":"Zajicek","year":"1985","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2005.02.027_bib39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/78688","article-title":"Fas engagement accelerates liver regeneration after partial hepatectomy","volume":"6","author":"Desbarats","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2005.02.027_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2567.2004.01932.x","article-title":"Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment","volume":"113","author":"Habu","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2005.02.027_bib41","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3","article-title":"Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide","volume":"30","author":"Osman","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib42","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.165.9.4917","article-title":"A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen","volume":"165","author":"Hameg","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib43","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.1833166100","article-title":"The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2005.02.027_bib44","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.171.8.4020","article-title":"Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells","volume":"171","author":"Crowe","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2005.02.027_bib46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:47:47Z","timestamp":1683089267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827805002655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0168827805002655"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2005.02.027","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}